BRPI0209720A2 - dosagem e embalagem de medicação com liberação controlada - Google Patents

dosagem e embalagem de medicação com liberação controlada

Info

Publication number
BRPI0209720A2
BRPI0209720A2 BRPI0209720A BRPI0209720A BRPI0209720A2 BR PI0209720 A2 BRPI0209720 A2 BR PI0209720A2 BR PI0209720 A BRPI0209720 A BR PI0209720A BR PI0209720 A BRPI0209720 A BR PI0209720A BR PI0209720 A2 BRPI0209720 A2 BR PI0209720A2
Authority
BR
Brazil
Prior art keywords
dosage
packaging
controlled release
release medication
medication
Prior art date
Application number
BRPI0209720A
Other languages
English (en)
Portuguese (pt)
Inventor
V Gumaste Anand
L Abrams Andrew
Original Assignee
Microdose Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Tech Inc filed Critical Microdose Tech Inc
Publication of BRPI0209720A2 publication Critical patent/BRPI0209720A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
BRPI0209720A 2001-05-31 2002-05-22 dosagem e embalagem de medicação com liberação controlada BRPI0209720A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29478601P 2001-05-31 2001-05-31
PCT/US2002/016185 WO2002096347A2 (en) 2001-05-31 2002-05-22 Metering and packaging of controlled release medication

Publications (1)

Publication Number Publication Date
BRPI0209720A2 true BRPI0209720A2 (pt) 2017-06-13

Family

ID=23134944

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0209720A BRPI0209720A2 (pt) 2001-05-31 2002-05-22 dosagem e embalagem de medicação com liberação controlada

Country Status (8)

Country Link
EP (1) EP1408907A4 (ja)
JP (1) JP2005514966A (ja)
AU (1) AU2002303840A1 (ja)
BR (1) BRPI0209720A2 (ja)
CA (3) CA2614899A1 (ja)
NZ (1) NZ529696A (ja)
WO (1) WO2002096347A2 (ja)
ZA (1) ZA200402466B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
JP2009511191A (ja) * 2005-10-14 2009-03-19 マイクロドース・テクノロジーズ・インコーポレーテッド 経口投与剤組合せ型医薬パッケージ法
EP2063771A1 (en) 2007-03-09 2009-06-03 Proteus Biomedical, Inc. In-body device having a deployable antenna
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
MY154217A (en) 2008-08-13 2015-05-15 Proteus Digital Health Inc Ingestible circuitry
MY161146A (en) 2009-04-28 2017-04-14 Proteus Digital Health Inc Highly-reliable ingestible event markers and methods for using the same
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
CA2795746C (en) 2010-04-07 2019-10-01 Timothy Robertson Miniature ingestible device
JP2014504902A (ja) * 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド 医薬品を有する摂取可能なデバイス
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
ES2967970T3 (es) 2012-07-23 2024-05-06 Otsuka Pharma Co Ltd Técnicas para fabricar marcadores de eventos ingeribles que comprenden un componente ingerible
AU2013331417B2 (en) 2012-10-18 2016-06-02 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
JP2016508529A (ja) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス， インコーポレイテッド 高度に膨張可能なポリマーフィルムおよびこれを含む組成物
JP5941240B2 (ja) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド 金属検出器装置、システム、および方法
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
SG11201900511VA (en) 2016-07-22 2019-02-27 Proteus Digital Health Inc Electromagnetic sensing and detection of ingestible event markers
CA3041041A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
TW202126301A (zh) * 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5699649A (en) 1996-07-02 1997-12-23 Abrams; Andrew L. Metering and packaging device for dry powders
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication

Also Published As

Publication number Publication date
CA2448997A1 (en) 2002-12-05
NZ529696A (en) 2008-07-31
JP2005514966A (ja) 2005-05-26
CA2614902A1 (en) 2002-12-05
CA2614899A1 (en) 2002-12-05
AU2002303840A1 (en) 2002-12-09
WO2002096347A3 (en) 2003-03-27
EP1408907A2 (en) 2004-04-21
WO2002096347A2 (en) 2002-12-05
EP1408907A4 (en) 2010-02-24
ZA200402466B (en) 2006-07-26

Similar Documents

Publication Publication Date Title
BRPI0209720A2 (pt) dosagem e embalagem de medicação com liberação controlada
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
DE60115418D1 (de) Mikroinfusionsvorrichtung zur verabreichung von medikamenten
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
NO20033384L (no) Farmasoytisk formulering
GB0117618D0 (en) Pharmaceutical dosage form
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
DE60225014D1 (de) Pharmazeutische zusammensetzungen von amlodipin und atorvastatin
ECSP045171A (es) Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia
NO20035627D0 (no) Farmasöytisk formulering
ATE324883T1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
ITBO20010005U1 (it) Distributore automatico di medicinali
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE60214533D1 (de) Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen
UA4167S (uk) Набір упаковок для ліків «метрозол»
UA4854S (uk) Упаковка медичного препарату
UA6050S (uk) Упакування медичного препарату
UA6049S (uk) Упакування медичного препарату

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI